Medical recertification of pilots with prior COVID-19 infection

The Federal Aviation Administration’s Office of Aerospace Medicine needs to maintain and update aeromedical certification guidance addressing a pilot’s fitness for duty after acute infection by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The Office of Aerospace Medicine aspires to use Evidence Based Risk Assessment (EBRA) as the foundation for aeromedical decision making. EBRA leverages the existing body of published clinical and population health research to generate suitable risk estimates to inform aeromedical decisions. This research project will carry out periodic reviews of the scientific literature from 2022 through 2025 to determine the post-acute infection recovery modes exhibited by the general U.S. population at least 18 years of age, and within each recovery mode, determine the risks of (1) progression of infection-related morbidity over a yearly certification period; (2) development of a potentially incapacitating medical condition; and (3) occupationally significant degradation in ability to perform a pilot’s safety sensitive functions. This project will also recommend risk-based guidelines for aeromedical evaluations based on recovery mode to include additional clinical or functional assessments relative to the proscribed standard aeromedical exam and aviation appropriate cut points for interpreting additional clinical or functional assessments.